Skip to content

Clinical trials

Completed Immune System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Status: Completed Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20102
20121
20131
20142
20151
20162
20173
20183
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Pfizer3
UCB Pharma2
Baxalta now part of Shire1
Bioverativ, a Sanofi company1
Celgene1
Eli Lilly and Company1
Erasmus Medical Center1
Heinrich-Heine University, Duesseldorf1
Jasper Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases19
Autoimmune Diseases9
Connective Tissue Diseases4
Hypersensitivity4
Hypersensitivity, Immediate4
Lupus Erythematosus, Systemic4
Immunoproliferative Disorders3
Lymphatic Diseases3
Lymphoma3
Lymphoma, Large B-Cell, Diffuse3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.